HIPRA Biotech Services' End-to-End Biologics Offering

Building on the HIPRA Group’s 50-year legacy in animal health, with over 100 registered vaccines and products in its portfolio, HIPRA Biotech Services is now bringing that expertise to human health. As a full-service biologics CDMO, HIPRA Biotech Services provides end-to-end solutions spanning mammalian and microbial drug substance manufacturing through to sterile fill-finish.